SILObenzinga

Silo Pharma Enters Into Service Agreement With Resyca BV For Drug-Device Study Of Formulation-Specific Microchip-Based Nasal Spray System Used In PTSD Drug SPC-15

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 21, 2025 by benzinga

    Silo Pharma Enters Into Service Agreement With Resyca BV For Drug-Device Study Of Formulation-Specific Microchip-Based Nasal Spray System Used In PTSD Drug SPC-15 | SILO Stock News | Candlesense